Institutional ownership · Form 13F

PGEN institutional ownership

Precigen, Inc. - Common Stock: reported institutional holdings as of 2026-06-30 (filed through 2026-08-31), aggregated by StockEyes from SEC Form 13F information tables. PGEN is one of 2732 tickers in the validated publication set. Mapping coverage in this publication set: 4562 of 6046 universe tickers have at least one validated CUSIP mapping (75.5%). Latest-quarter filed value resolved to any listed ticker: 77.3%; resolved to this universe: 77.2%.

Quarter ended2026-06-30 Filed through2026-08-31 Reporting managers211 Reported shares140,489,599 Value as filed$794,863,340
What changed this quarter

PGEN: change since the prior quarter's filings

More managers reported a position, with the count rising from 205 in the quarter ended 2026-03-31 to 211 in the quarter ended 2026-06-30 (+6, 2.9%). Total reported shares rose to 140,489,599 (+6,873,444, 5.1%), moving the same way as the manager count. Among the 25 managers listed as top holders in both quarters, the largest increases were Diametric Capital, LP (+2,468,138 shares) and BlackRock, Inc. (+1,923,730 shares), among 18 managers who added shares, and the largest decreases were Point72 Asset Management, L.P. (-5,377,682 shares) and CITADEL ADVISORS LLC (-1,881,994 shares), among 6 managers who reduced shares. FIRST TRUST ADVISORS LP (2,014,659 shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1,788,235 shares) and 3 more entered the listed top holders; JANE STREET GROUP, LLC (1,821,790 shares in the prior quarter), Corient Private Wealth LLC (911,206 shares in the prior quarter) and 3 more dropped out of the listed top holders.

New to 13F data? Read how to read a 13F filing, or see where institutions moved overall in the Smart Money Report.

As filed

Reported totals, quarter ended 2026-06-30

211 reporting managers held 140,489,599 shares, reported value $794,863,340 exactly as filed. Values are position values transcribed from the filings, not current market prices.

Reported quarter-over-quarter change (quarter ended 2026-03-31 to quarter ended 2026-06-30): reporting managers +6, reported shares +6,873,444 (+5.14%), reported value +55.41%. These changes compare two filing snapshots.

Shares outstanding check: 356,893,568 shares reported by the issuer (SEC XBRL, period ended 2026-06-30). Reported 13F shares equal 39.4% of that figure. This page passed the publication sanity gate before listing.

What the data shows

PGEN in this quarter's filings

Concentration check: the largest reported position, Patient Capital Management, LLC with 19,036,976 shares, is 13.6% of all shares reported for PGEN this quarter. The five largest reporting managers together account for 46.5% of the reported total, so the headline total is spread across a broad manager base rather than a few holders.

Reported quarter-over-quarter change: the reporting-manager count rose by 6 versus the quarter ended 2026-03-31, and reported shares moved +5.14% (+6,873,444 shares). That is a comparison of two filing snapshots, not a record of trades on any single day.

Shares-outstanding cross-check: reported 13F shares equal 39.4% of the issuer share count used at the publication gate (356,893,568 shares, issuer period ended 2026-06-30). The gate publishes a ticker only when that relationship is plausible; lending chains can push reported totals above a simple ownership share, which is why the figure is a sanity check and not an ownership percentage.

Top holders as filed

Largest reporting managers, PGEN

PGEN largest 13F reporting managers, quarter ended 2026-06-30
#ManagerSharesValue as filedShare of reported total
1Patient Capital Management, LLC19,036,976$108,510,76013.6%
2BlackRock, Inc.17,146,921$97,737,45012.2%
3STATE STREET CORP12,002,465$68,414,0518.5%
4Diametric Capital, LP9,269,926$52,838,5786.6%
5VANGUARD CAPITAL MANAGEMENT LLC7,906,160$45,065,1125.6%
6TANG CAPITAL MANAGEMENT LLC6,417,500$36,579,7504.6%
7Boxer Capital Management, LLC5,150,000$29,355,0003.7%
8GEODE CAPITAL MANAGEMENT, LLC5,019,028$28,612,9113.6%
9IRIDIAN ASSET MANAGEMENT LLC/CT4,031,963$22,982,1892.9%
10MORGAN STANLEY3,469,628$19,776,8852.5%
11Occam Crest Management LP3,605,941$19,652,3782.6%
12GOLDMAN SACHS GROUP INC3,406,456$19,416,7972.4%
13FMR LLC2,570,183$14,650,0461.8%
14VANGUARD PORTFOLIO MANAGEMENT LLC2,211,172$12,603,6801.6%
15FIRST TRUST ADVISORS LP2,014,659$11,483,5561.4%

Manager names and figures are transcribed from each manager's own Form 13F information table. A manager listing shares in this snapshot does not mean it holds them today.

Quarter comparison

Reported change, 2026-03-31 to 2026-06-30

PGEN reported 13F totals by quarter
Quarter endedFiled throughReporting managersReported sharesValue as filed
2026-03-312026-05-29205133,616,155$511,452,116
2026-06-302026-08-31211140,489,599$794,863,340

Every change figure on this page is a reported quarter-over-quarter change between filing snapshots. It is not real-time trading activity.

Reported history

PGEN reported totals over time

Quarter ended 2026-06-30: 211 reporting managers · 140,489,599 reported shares · $794,863,340 value as filed.

The full archived series is part of StockEyes Pro. Continue with Google to sign in.

Quarter-end 13F filed data, long positions only; filings arrive up to 45 days after quarter end.

Coverage for this ticker

CUSIPs behind the PGEN total

The validated bridge mapped 1 current CUSIP(s) to PGEN for this quarter: 74017N105. Option pseudo-CUSIPs, units, warrants, and preferred classes are excluded from these common-share totals. Mapping coverage in this publication set: 4562 of 6046 universe tickers have at least one validated CUSIP mapping (75.5%). Latest-quarter filed value resolved to any listed ticker: 77.3%; resolved to this universe: 77.2%.

Read this first

What this page is and is not

Form 13F reports are quarterly holdings snapshots. Managers file up to about 45 days after quarter-end, so these figures describe reported positions as of the quarter-end date, not holdings today. 13F lists reportable long positions from managers above the SEC reporting threshold and omits short positions entirely.

This page is informational only. It is not investment advice, a recommendation, or a signal to buy or sell. Source: SEC Form 13F bulk data set for filings through 2026-08-31 (period ended 2026-06-30), joined to tickers through StockEyes' validated CUSIP bridge. Methodology and coverage are documented on the institutional ownership hub.

Insider transactions for PGEN (officer and director buys and sells) are covered by InsiderTrace: insidertrace.com/stock/pgen. StockEyes does not duplicate insider transaction tables.

Keep researching

Related StockEyes pages

Latest headlines tagged PGEN are on the market news wire. Upcoming earnings and market dates are on the events calendar. The term itself is defined in the institutional investor glossary entry, and the research workflow behind pages like this one is walked through in how to research a stock and how to compare SEC filings.

← All institutional ownership